Harpoon Therapeutics Company

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Technology: Biologics, CAR-T therapy
Industry: PharmTech, Public
Headquarters: South San Francisco, California, United States
Founded Date: 2015-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 10
Total Funding: 130000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-11-12
Last Funding Type: Series C

Visit Website
Register and Claim Ownership